Synopsis
PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Episodes
-
![Lisa H. Lancaster, MD - Updates in Interstitial Lung Disease: Making Strides in Accurate Diagnosis and Optimized Treatment]()
Lisa H. Lancaster, MD - Updates in Interstitial Lung Disease: Making Strides in Accurate Diagnosis and Optimized Treatment
06/08/2018 Duration: 01h01minUpdates in Interstitial Lung Disease: Making Strides in Accurate Diagnosis and Optimized Treatment
-
![Nicola A. Hanania, MD, MS - Exploring the Latest Data in the Treatment of Uncontrolled Persistent Asthma: Clinical Highlights From San Diego]()
Nicola A. Hanania, MD, MS - Exploring the Latest Data in the Treatment of Uncontrolled Persistent Asthma: Clinical Highlights From San Diego
03/08/2018 Duration: 30minExploring the Latest Data in the Treatment of Uncontrolled Persistent Asthma: Clinical Highlights From San Diego
-
![George D. Demetri, MD - Making the TRK to Precision Medicine in Cancer: The Promise of Targeting TRK Fusions in Lung, Breast, GI, and Other Tumors]()
George D. Demetri, MD - Making the TRK to Precision Medicine in Cancer: The Promise of Targeting TRK Fusions in Lung, Breast, GI, and Other Tumors
20/07/2018 Duration: 01h10minMaking the TRK to Precision Medicine in Cancer: The Promise of Targeting TRK Fusions in Lung, Breast, GI, and Other Tumors
-
![Edward B. Garon, MD, MS - Realizing the Potential of Precision Oncology in Lung Cancer—Challenges and Opportunities: Strengthening the Partnership Between Oncology and Pathology to Make the Most of the Latest Diagnostics and Therapies]()
Edward B. Garon, MD, MS - Realizing the Potential of Precision Oncology in Lung Cancer—Challenges and Opportunities: Strengthening the Partnership Between Oncology and Pathology to Make the Most of the Latest Diagnostics and Therapies
18/07/2018 Duration: 01h39minRealizing the Potential of Precision Oncology in Lung Cancer—Challenges and Opportunities: Strengthening the Partnership Between Oncology and Pathology to Make the Most of the Latest Diagnostics and Therapies
-
![Farhad Ravandi, MD - Making Therapeutic Choices for Diverse AML Populations: Exploring New Science, More Effective Treatment Options, and Impact on Patient Care]()
Farhad Ravandi, MD - Making Therapeutic Choices for Diverse AML Populations: Exploring New Science, More Effective Treatment Options, and Impact on Patient Care
16/07/2018 Duration: 01h32minMaking Therapeutic Choices for Diverse AML Populations: Exploring New Science, More Effective Treatment Options, and Impact on Patient Care
-
![Robert Z. Orlowski, MD, PhD - A Personal Look at Innovative Therapy and Meeting Patient Needs in Multiple Myeloma: How I Think, How I Treat]()
Robert Z. Orlowski, MD, PhD - A Personal Look at Innovative Therapy and Meeting Patient Needs in Multiple Myeloma: How I Think, How I Treat
13/07/2018 Duration: 01h34minA Personal Look at Innovative Therapy and Meeting Patient Needs in Multiple Myeloma: How I Think, How I Treat
-
![Naiyer Rizvi, MD - Emerging Biomarkers, New Targets, and Rational Combinations: Are We on the Verge of the Next Generation of Immuno-Oncology?]()
Naiyer Rizvi, MD - Emerging Biomarkers, New Targets, and Rational Combinations: Are We on the Verge of the Next Generation of Immuno-Oncology?
11/07/2018 Duration: 01h51minEmerging Biomarkers, New Targets, and Rational Combinations: Are We on the Verge of the Next Generation of Immuno-Oncology?
-
![John P. Leonard, MD - The Arrival of Novel Agent Classes in B-Cell Non-Hodgkin Lymphoma: A Personal Guide to Integrating New Therapy Into Patient Care]()
John P. Leonard, MD - The Arrival of Novel Agent Classes in B-Cell Non-Hodgkin Lymphoma: A Personal Guide to Integrating New Therapy Into Patient Care
09/07/2018 Duration: 01h40minThe Arrival of Novel Agent Classes in B-Cell Non-Hodgkin Lymphoma: A Personal Guide to Integrating New Therapy Into Patient Care
-
![Jonathan Corren, MD - Targeted Treatment in Severe Asthma: Moving Toward Precision Medicine]()
Jonathan Corren, MD - Targeted Treatment in Severe Asthma: Moving Toward Precision Medicine
06/07/2018 Duration: 23minTargeted Treatment in Severe Asthma: Moving Toward Precision Medicine
-
![Fernando J. Martinez, MD, MS - Evaluating New Advances in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases: Updates From San Diego]()
Fernando J. Martinez, MD, MS - Evaluating New Advances in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases: Updates From San Diego
04/07/2018 Duration: 25minEvaluating New Advances in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases: Updates From San Diego
-
![Charles V. Pollack, MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP - Reversal of Action: Addressing the Unmet Need for Universal Antidotes to Factor Xa Anticoagulants]()
Charles V. Pollack, MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP - Reversal of Action: Addressing the Unmet Need for Universal Antidotes to Factor Xa Anticoagulants
29/06/2018 Duration: 35minReversal of Action: Addressing the Unmet Need for Universal Antidotes to Factor Xa Anticoagulants
-
![Monica Kraft, MD - Optimizing Asthma Control Through Accurate Identification, Evidence-Based Management, and Targeted Therapeutic Options]()
Monica Kraft, MD - Optimizing Asthma Control Through Accurate Identification, Evidence-Based Management, and Targeted Therapeutic Options
21/06/2018 Duration: 29minOptimizing Asthma Control Through Accurate Identification, Evidence-Based Management, and Targeted Therapeutic Options
-
![Jonathan G. Goldin, MD, PhD, David J. Lederer, MD, MS - Achieving Early and Accurate Diagnosis of Interstitial Lung Disease]()
Jonathan G. Goldin, MD, PhD, David J. Lederer, MD, MS - Achieving Early and Accurate Diagnosis of Interstitial Lung Disease
19/06/2018 Duration: 41minAchieving Early and Accurate Diagnosis of Interstitial Lung Disease
-
![Robin Lachmann, MD, PhD - Diagnosing and Treating Acid Sphingomyelinase Deficiency: The Potential Impact of New Consensus Recommendations and Ongoing Clinical Trials of Emerging Therapies]()
Robin Lachmann, MD, PhD - Diagnosing and Treating Acid Sphingomyelinase Deficiency: The Potential Impact of New Consensus Recommendations and Ongoing Clinical Trials of Emerging Therapies
04/06/2018 Duration: 14minDiagnosing and Treating Acid Sphingomyelinase Deficiency: The Potential Impact of New Consensus Recommendations and Ongoing Clinical Trials of Emerging Therapies
-
![Reynold A. Panettieri, Jr., MD - The Role of the Eosinophil in COPD: Implications for Precision Care and Novel Treatments]()
Reynold A. Panettieri, Jr., MD - The Role of the Eosinophil in COPD: Implications for Precision Care and Novel Treatments
01/06/2018 Duration: 13minThe Role of the Eosinophil in COPD: Implications for Precision Care and Novel Treatments
-
![Christian T. Ruff, MD, MPH - Making the Connection: A Call to Action Against Undiagnosed Atrial Fibrillation—Improving Detection, Reducing Risk]()
Christian T. Ruff, MD, MPH - Making the Connection: A Call to Action Against Undiagnosed Atrial Fibrillation—Improving Detection, Reducing Risk
28/05/2018 Duration: 35minMaking the Connection: A Call to Action Against Undiagnosed Atrial Fibrillation—Improving Detection, Reducing Risk
-
![Emma Guttman-Yassky, MD, PhD - New Developments in Allergic and Inflammatory Diseases: Clinical Updates From San Diego and Orlando]()
Emma Guttman-Yassky, MD, PhD - New Developments in Allergic and Inflammatory Diseases: Clinical Updates From San Diego and Orlando
24/05/2018 Duration: 39minNew Developments in Allergic and Inflammatory Diseases: Clinical Updates From San Diego and Orlando
-
![Paul Richardson, MD - Integrated Myeloma Management for Transplant-Eligible Patients: The Conjunction of Novel Therapeutic Platforms, Innovative Agents, and HCT]()
Paul Richardson, MD - Integrated Myeloma Management for Transplant-Eligible Patients: The Conjunction of Novel Therapeutic Platforms, Innovative Agents, and HCT
22/05/2018 Duration: 52minIntegrated Myeloma Management for Transplant-Eligible Patients: The Conjunction of Novel Therapeutic Platforms, Innovative Agents, and HCT
-
![Anas Younes, MD - Treatment Innovation in Hodgkin Lymphoma: Integrating New Therapeutic Options With Autologous Transplant Across Clinical Settings]()
Anas Younes, MD - Treatment Innovation in Hodgkin Lymphoma: Integrating New Therapeutic Options With Autologous Transplant Across Clinical Settings
09/05/2018 Duration: 40minTreatment Innovation in Hodgkin Lymphoma: Integrating New Therapeutic Options With Autologous Transplant Across Clinical Settings
-
![Jorge E. Cortes, MD - Novel Induction Options in AML: Assessing the Implications for HCT-Eligible Patients]()
Jorge E. Cortes, MD - Novel Induction Options in AML: Assessing the Implications for HCT-Eligible Patients
04/05/2018 Duration: 54minNovel Induction Options in AML: Assessing the Implications for HCT-Eligible Patients
